US trial sought for BiodivYsio drug-coated stent
This article was originally published in Clinica
Executive Summary
Biocompatibles International and British Biotech have filed an application with the FDA to begin a pivotal clinical trial of a drug-coated stent that is being developed jointly by the two firms.